« Back to Record
Citation APA

Rimassa, L., Trojan, J., De Toni, E. E., Weiss, A., Miles, S., Gasbarrini, A., Lencioni, M., Lamar, M. E., Wang, Y., Shuster, D., Schwartz, B., Abbadessa, G., Santoro, A., Personeni, N., Porta, C., Borbath, I., Daniele, B., Salvagni, S., Van Laethem, J.-L., & Van Vlierberghe, H. (2016). Tumor and circulating biomarkers in patients with second-line hepatocellular carcinoma from the randomized phase II study with tivantinib. Oncotarget, 7(45), 72622-72633. doi:10.18632/oncotarget.11621


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/243891

Rimassa, L., Trojan, J., De Toni, E. E., Weiss, A., Miles, S., Gasbarrini, A., Lencioni, M., Lamar, M. E., Wang, Y., Shuster, D., Schwartz, B., Abbadessa, G., Santoro, A., Personeni, N., Porta, C., Borbath, I., Daniele, B., Salvagni, S., Van Laethem, J.-L., & Van Vlierberghe, H. (2016). Tumor and circulating biomarkers in patients with second-line hepatocellular carcinoma from the randomized phase II study with tivantinib. Oncotarget, 7(45), 72622-72633. doi:10.18632/oncotarget.11621